May 14, 2019

Cordis Launches Radial 360 Portfolio for Interventional Cardiology Procedures

May 14, 2019—Cordis, a Cardinal Health company, announced the full launch of its Radial 360 portfolio in the United States. The Radial 360 portfolio offers a complete range of products to facilitate the transradial approach for interventional cardiology procedures.

According to Cordis, the launch marks the beginning of the global rollout of its radial product portfolio. The Cordis Radial 360 portfolio is composed of the Rain Sheath transradial thin-walled introducer; the Railway sheathless access system; the RBL-TG and RBL-JK universal shapes for the Infiniti and Super Torque Plus diagnostic catheters; and the Zephyr vascular compression band.

The Rain Sheath device features an ultra-low–profile design, lubricious hydrophilic coating, and the company's Kin Recovery Technology that enables the sheath to maintain lumen patency throughout the procedure, even after a kink occurs.

The Railway system received European CE Mark approval in March 2017 and FDA clearance in April 2018.

Kintur Sanghvi, MD, Associate Medical Director of Interventional Cardiology at Deborah Heart & Lung Center in Browns Mills, New Jersey, is the inventor of the Railway system. In the company's press release, Dr. Sanghvi commented, "The transradial approach has been an important advancement in how we treat coronary artery disease because of both the patient benefits and the advantages realized by the hospital in terms of procedure flow and economics. We look to the industry to help us advance the tools available for this technique, which Cordis has done with the introduction of the Radial 360 portfolio."

Dr. Sanghvi added, "In my experience with the Railway system, I see the clear advantage of downsizing the radial access by up to 2 F, a benefit that I'm unable to achieve with anything else that's currently on the market."

Kevin Croce, MD, Director of the Chronic Total Occlusion Complex Percutaneous Coronary Intervention (PCI) Program at Brigham and Women's Hospital in Boston, Massachusetts, stated, "It's really exciting to have new and innovative tools to support complex radial revascularization procedures for our patients. These improvements in sheath and catheter technologies will enable us to increase radial adoption in the United States so that we can maximize PCI success while minimizing bleeding complications."


May 14, 2019

Staged PCI for Complete Revascularization Compared With Culprit Vessel–Only PCI for STEMI and Multivessel CAD

May 13, 2019

FDA Approves Extended Duration of Use for Abiomed's Impella Heart Pumps to Treat Cardiogenic Shock